ArticleJournal of clinical microbiology2021
Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations.
Open access · greenAbstract read
In one paragraph
Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 50 citations in OpenAlex.
- Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026Article
- Genomic landscape and fine-scale population structure of Helicobacter pylori across China.Biomarker research · 2026Article
- Levofloxacin and Rifampin Resistance inAntibiotics (Basel, Switzerland) · 2026Article
- Helicobacter pylori antimicrobial resistance and gene variants in Shandong Province.Scientific reports · 2025Article
- Inherited Susceptibility to Cancer: Past, Present and Future.Annals of human genetics · 2025Review
- Population structure ofJournal of clinical microbiology · 2025Article
- Resistome and virulome determination inMicrobiology spectrum · 2025Article
- Overcoming antibiotic-resistantWorld journal of gastroenterology · 2025Review
- Analysis of antibiotic susceptibility and genomic characteristics of Helicobacter pylori by whole-genome resequencing in Northern China.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Multiplex PCR-Mass Spectrometry Mini-Sequencing Technology Detected Antibiotic Resistance ofInternational journal of molecular sciences · 2025Article
- Helicobacter pylori Infection in Colombia: Phylogeny, Resistome, and Virulome.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025Article
- RdxA-independent mechanism ofFrontiers in microbiology · 2025Article
- First insight into the whole genome sequence variations in clarithromycin resistant Helicobacter pylori clinical isolates in Russia.Scientific reports · 2024Article
- Antimicrobial susceptibility of clinicalMicrobiology spectrum · 2024Article
- Anti-inflammatory effects of extracellular vesicles and cell-free supernatant derived from Lactobacillus crispatus strain RIGLD-1 on Helicobacter pylori-induced inflammatory response in gastric epithelial cells in vitro.Folia microbiologica · 2024Article
- Point Mutations in Furazolidone and Rifampicin Resistance Genes inAntibiotics (Basel, Switzerland) · 2024Article
- Anti-Evidence-based complementary and alternative medicine : eCAM · 2024Article
- Article
- Simultaneous Detection ofInfection and drug resistance · 2024Article
- Antibiotic Resistance Rates forMicroorganisms · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Anthony Mannion *Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-6112-0546
JoAnn Dzink-Fox *Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Zeli Shen *Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
M Blanca PiazueloVanderbilt University, Nashville, Tennessee, USA.
Keith T WilsonVanderbilt University, Nashville, Tennessee, USA.
Pelayo CorreaVanderbilt University, Nashville, Tennessee, USA.
Richard M PeekVanderbilt University, Nashville, Tennessee, USA.
M Constanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA jgfox@mit.edu.ORCID 0000-0001-9307-6116
Massachusetts Institute of Technology · USVanderbilt University · USNational Cancer Institute · US
Funding
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9MRole of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 2009 to 2026
$27.5MTOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6MProject 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8MH.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7MHelicobacter Pylori and Gastrointestinal BiologyR01DK058587 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEK, RICHARD M. · 2001 to 2024
$7.8MMolecular mechanisms of infection-related cancerZIACP010212 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2010 to 2025
$4.6MTargeted chemoprevention of gastric carcinogenesis in high risk populationsR01CA190612 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MORGAN, DOUGLAS, WILSON, KEITH T. · 2014 to 2018
$3.0MDysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease ProgressionI01CX002171 · VA · VETERANS HEALTH ADMINISTRATION · PI Keith T. Wilson · 2020 to 2026
–Arginine Availability and Metabolism in the Immune Evasion of H. pyloriI01BX001453 · VA · VETERANS HEALTH ADMINISTRATION · PI WILSON, KEITH T. · 2012 to 2019
–BLRD VA I01 BX001453CSRD VA I01 CX002171NCI NIH HHS P01 CA028842NCI NIH HHS P01 CA116087NCI NIH HHS R01 CA077955NCI NIH HHS R01 CA190612NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK058587NIEHS NIH HHS P30 ES002109
Abstract
Colombia, South America has one of the world's highest burdens of
Indexed as
Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAnti-Bacterial AgentsClarithromycinColombiaDrug Resistance, BacterialHumansMetronidazoleMicrobial Sensitivity TestsPhylogenyRNA, Ribosomal, 16SRNA, Ribosomal, 23SSouth AmericaAnti-Bacterial AgentsClarithromycinMetronidazoleRNA, Ribosomal, 16SRNA, Ribosomal, 23Sadaptive mutationsantibiotic resistanceantimicrobial susceptibility testingColombiaHelicobacter pylorilevofloxacinmetronidazolePCRSouth Americawhole-genome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.